In a stride toward enhancing cancer treatment, University of Birmingham researchers are using organ-on-a-chip technology to imitate the liver's environment and improve immunotherapy for liver cancer.
May 21, 2024
0
0
Scientists are reporting a test which can predict which patients are most at risk from aggressive prostate cancer, and whether they suffer an increased chance of treatment failure. This test, reported at the European Association ...
Mar 28, 2017
0
0
The new type of magnetic resonance imaging (MRI) scan could improve care for a type of cancer called myeloma and reduce reliance on bone marrow biopsies, which can be painful for patients and often fail to show doctors how ...
Jan 28, 2014
0
0
New research from VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center indicates that survivors of childhood cancer are at a significantly higher risk of death following a major cardiovascular event—including ...
Feb 27, 2024
0
1
A drug developed at Linköping University in Sweden protects against the side effects of cancer treatments while strengthening the effects on the tumour. An international drug evaluation is now starting up on a larger group ...
Jan 22, 2013
0
0
Bone marrow is the soft tissue inside bones. Its main role is to produce stem cells that will go on to become cells of the blood, including white blood cells that fight infections, red blood cells that carry oxygen throughout ...
Sep 28, 2020
0
1
Researchers at UT Southwestern Medical Center have identified a novel parameter of T cells that could help oncologists anticipate which patients would be most likely to develop immunotherapy toxicity. The findings, published ...
Aug 14, 2023
0
11
Primary liver cancer is on the rise worldwide, largely due to an increase in hepatitis C infections and chronic liver disease. Liver cancer is also hard to treat—it kills 750,000 people a year worldwide, making it the second ...
Dec 15, 2020
0
0
Many people don't realize that cancer patients are in constant need of blood supplies.
Feb 19, 2020
0
2
A new study conducted by MedUni Vienna in collaboration with scientists from Hungary and Sweden has now shown for the first time that the success of specialised drugs to inhibit blood supply to tumours – so-called angiogenesis ...
Jan 24, 2017
0
1
